Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Mercury Pharma Group Ltd., Capital House, 85 King William Street, London EC4N 7BL, UK
Topical analgesic and anti-inflammatory for backache, pain of non-serious arthritic conditions, muscular pain, sprains, strains, sports injuries and neuralgia.
Topical analgesic and anti-inflammatory for backache, rheumatic and muscular pain, sprains, strains and sports injuries.
Strength 5% maximum.
Squeeze 50 to 125mg (4 to 10cm) of the gel from the tube and lightly rub into the affected area until absorbed. The dose should not be repeated more frequently than every four hours and no more than 4 times in any 24 hour period. Wash hands after each application. DO NOT USE MORE GEL THAN THE LABEL TELLS YOU TO.
Review treatment after 2 weeks, especially if the symptoms worsen or persist.
Do not use on children under 12 years of age except on the advice of a doctor.
For topical application to the skin.
Overdosage with a topical presentation of ibuprofen gel is unlikely.
Symptoms of severe ibuprofen overdosage (eg following accidental oral ingestion) include headache, vomiting, drowsiness and hypotension.
Correction of severe electrolyte abnormalities should be considered.
36 months.
Store below 25°C.
Aluminium tube with internal epoxy phenolic coating with Polypropylene cap containing 15g (trial size/starter pack) and 30/35/50/100g of Fenbid Gel/Phorpain Gel. The 100g pack size is restricted to “Pharmacy” only. Not all pack sizes may be marketed.
No special requirements for disposal.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
